This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

THOMAS BUTTERWORTH, M.D., Med. Sc.M.; LYON P. STREAN, Ph.D., D.D.S.

Arch Dermatol. 1961;84(6):964-971.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

In recent years rheumatologists have been using a combination of steroids and salicylates in the management of rheumatic fever and various arthritides. Many believe that the 2 drugs are synergistic, giving results superior to either alone. By employing smaller doses of the 2 drugs, the side effects are less frequent than when one agent is administered alone in higher dosage. Applying this principle to dermatology, we have used salicylates with steroidal agents in many subacute and chronic dermatoses in which the latter were recommended. We have observed favorable results in exfoliative, atopic, contact, and widespread seborrheic dermatitides, psoriatic erythroderma, and erythema multiforme. By continuing the use of salicylates, it has been possible in many instances to stop the steroids without the "rebound phenomenon" so frequently observed when they are withdrawn. Because of the difficulty of securing a control group of patients, interpretation of results was necessarily subjective.

We have selected . . . [Full Text PDF of this Article]

Author Affiliations
READING, PA.; NORRISTOWN, PA.

Footnotes
Submitted for publication July 21, 1961.

Read before the 81st Annual Meeting of the American Dermatological Association, Inc., Tucker's Town, Bermuda, June 20, 1961.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?